Close

Production & Manufacturing

Automated Inspection with HV Leak Detection Systems

Ensuring the absolute integrity of pharmaceutical packaging is a cornerstone of modern drug safety. The implementation of automated inspection with HV leak detection systems provides a high-sensitivity, non-destructive solution for identifying microscopic breaches in sterile containers. This approach significantly advances quality control by integrating high-voltage physics with high-speed automation, thereby safeguarding patients and maintaining rigorous regulatory compliance.

Axplora $60M Investment Expands HPAPI Manufacturing Capacity

Axplora has reached a key milestone in its ongoing investment strategy, advancing a $60 million programme dedicated to strengthening HPAPI manufacturing capabilities at its Farmabios site in Gropello Cairoli. The latest development involves the construction of a new 4,500...

Your Guide to Manufacturing and Operations Careers in the Life Sciences Industry

Companies in the life sciences industry can be extremely selective about whom they hire for manufacturing and operations roles. These positions demand more specialized skills and are subject to stricter regulatory compliance. This guide helps you overcome the usual...

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with a fresh wave of capital deployment, underscoring the country’s growing role in global pharmaceutical strategy. The company confirmed a Novartis China investment exceeding 3.3 billion Chinese yuan (roughly $480 million),...

Sustainable Nutraceutical Ingredients Shaping the Future

The Shift Toward Sustainable Ingredients One of the most significant transformations in the nutraceutical sector is the shift toward eco-friendly and responsibly sourced ingredients. Marine-Based Nutraceuticals Marine-derived ingredients such as seaweed, algae, and bioactive compounds are gaining traction due to their high efficacy...

High-Purity Ingredients: The New Benchmark in Nutraceuticals

In today’s competitive nutraceutical market, quality is no longer optional—it is essential. Consumers, regulators, and healthcare professionals are increasingly demanding products that deliver consistent results backed by science. As a result, high-purity ingredients are emerging as the new benchmark...

Why Integrated CDMO Partnerships Replace Multi-Vendor Models

Key Takeaways: The multi-vendor model in biopharma CMC creates communication risk, timeline gaps, and regulatory complexity Integrated CDMO partnerships consolidate development and manufacturing under a single organization with end-to-end knowledge of the process Single-partner models improve technology transfer efficiency...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »